Related party transactions
On 19 April 2018, the members of the board of directors and the executive committee were offered new warrants under Warrant Plan 2018, subject to acceptance. As of the date of this report, the acceptance period for Warrant Plan 2018 is still ongoing, so the final number of warrants granted to members of the board of directors and the executive committee cannot be determined yet. Under Warrant Plan 2018, the warrants have an exercise term of eight years as of the date of the offer. The exercise price of the warrants is €79.88. Each warrant gives the right to subscribe for one new Galapagos share. As regards the directors, the warrants vest over a period of 36 months at a rate of 1/36th per month. As regards the other beneficiaries, the warrants vest only and fully on the first day of the fourth calendar year following the calendar year in which the grant was made. The warrants are not transferable and can in principle not be exercised prior to 1 January 2022.
The table below sets forth the number of warrants offered under Warrant Plan 2018 to each member of the board and executive committee in office during the first six months of 2018:
Name |
Title |
Number of 2018 warrants offered |
||
|
||||
Onno van de Stolpe |
Chief Executive Officer; Executive director |
100,000 |
||
Raj Parekh |
Non-executive director; Chairman of the board |
15,000 |
||
Werner Cautreels |
Non-executive director |
7,500 |
||
Harrold van Barlingen(*) |
Non-executive director |
– |
||
Howard Rowe |
Non-executive director |
7,500 |
||
Katrine Bosley |
Non-executive director |
7,500 |
||
Christine Mummery |
Non-executive director |
7,500 |
||
Mary Kerr |
Non-executive director |
7,500 |
||
Piet Wigerinck |
Chief Scientific Officer |
60,000 |
||
Bart Filius |
Chief Operating Officer; Chief Financial Officer |
80,000 |
||
Andre Hoekema |
Chief Business Officer |
50,000 |
||
Walid Abi-Saab |
Chief Medical Officer |
60,000 |
During the first six months of 2018, there were no changes to related party transactions disclosed in the 2017 annual report that potentially had a material impact on the financials of the first six months of 2018.